Galinsoga parviflora (Cav.): A comprehensive review on ethnomedicinal, phytochemical and pharmacological studies

Asha Ripanda; Amos Luanda; Khalfani S Sule; Geoffrey S Mtabazi; John J Makangara

doi:10.1016/j.heliyon.2023.e13517

Galinsoga parviflora (Cav.): A comprehensive review on ethnomedicinal, phytochemical and pharmacological studies

Heliyon. 2023 Feb 8;9(2):e13517. doi: 10.1016/j.heliyon.2023.e13517. eCollection 2023 Feb.

Authors

Asha Ripanda¹, Amos Luanda¹, Khalfani S Sule¹, Geoffrey S Mtabazi¹, John J Makangara¹

Affiliation

¹ Department of Chemistry, College of Natural and Mathematical Sciences, The University of Dodoma, P.O. Box 338, Dodoma, Tanzania.

Abstract

Galinsoga parviflora (Cav.) is a member of the Asteraceae family traditionally used for treatment of various ailments such as malaria, flu, cold, colorectal cancer, liver problems and inflammation. The medicinal properties of G. parviflora are due to the presence of various secondary metabolites including flavonoids, saponins, terpenoids and tannins. The literature survey revealed that G. parviflora possesses several pharmacological properties such as antibacterial, antifungal, antioxidant and antidiabetic. This review systematically discusses the potential of G. parviflora for managing medical conditions. The information is collected from various online databases such as Google Scholar, ScienceDirect, Springer, Web of Science, Plant of the World Online and PubMed. Among other information provided in this review, ethnomedicinal uses, phytochemistry and pharmacological activities are discussed extensively. Additonally, the potential benefits, challenges and future opportunities are presented.

Keywords: Extracts; Galinsoga parviflora; Medical conditions; Medicinal plant; Pharmacological properties.

Publication types

Review